Tocilizumab in COVID-19: some clarity amid controversy. Gupta S, Leaf DE. Lancet 2021;397:1599-1601.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gupta S, Leaf DE. Tocilizumab in COVID-19: some clarity amid controversy. Lancet 2021;397:1599-1601.
PMID: 33933194